• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Catalog Number SEPX-8-6-40-135
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/25/2020
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician was attempting to use a protege rx self-expanding stent along with a 6mm spider fx embolic protection during procedure to treat a little calcified plaque lesion in the left mid common carotid artery with 70% stenosis.The vessel was little tortuous.The vessel diameter and lesion length are 6mm and 30mm respectively.There was no damage noted to packaging.There was no issue noted when removing device from hoop/tray.The device was prepped per ifu with no issues identified.Deployment issue occurred.It was reported that the physician was unable to deploy the stent.There was no resistance encountered during delivery to lesion.The device did not pass through a previously deployed stent.The thumbscrew/lock-pin were checked for securement prior to procedure.The lock-pin was removed when the stent was ready to be deployed after reaching the lesion and positioning.The lesion was not pre dilated.Stent struts were partially exposed during deployment attempt.A stent of the same model was replaced with to complete the procedure.There was no patient injury reported.
 
Manufacturer Narrative
Device evaluation visual inspection: the protégé rx was removed from the pouch and inspected.The tuohy-borst valve was loosened.A visual inspection showed the 4cm stent remained loaded the catheter shaft.No portion of the stent was exposed outside of the deployment system.Functional testing: a 0.014¿ guidewire from the lab could not be front of back loaded due to encountered resistance.The protégé rx was loaded the deployment apparatus from within the lab.3.44 of force was applied to the deployment grip, but the stent showed no signs of deployment.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
MDR Report Key10799463
MDR Text Key215280532
Report Number2183870-2020-00364
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/06/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/17/2021
Device Catalogue NumberSEPX-8-6-40-135
Device Lot NumberA934056
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/23/2020
Date Manufacturer Received02/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age90 YR
Patient Weight60
-
-